SOBECO

Drug that Quickly Reduces Alcohol Intoxication

Health Tech & Life Sciences
Non Active, Dec 2016
Pre-Funding Tel Aviv-Yafo, Israel Founded 2011
Last updated 2026-06-18
Total raised
Stage
Pre-Funding
Founded
2011
Headcount
6
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences

About

The Sobeco partnership focuses on developing bio-medical products. The partnership, established in November 2011, will work on R&D, patent writing, and partnering strategies. The partnership's objective is to reduce the number of alcohol-related car accidents and make the use of alcohol safer. Sobeco plans to develop a drug that can quickly eliminate the negative effects of alcohol on the body after moderate drinking.

Q&A

What is SOBECO's primary focus?
SOBECO focuses on developing bio-medical products, specifically a drug designed to quickly reduce alcohol intoxication and eliminate the negative effects of alcohol after moderate drinking.
When was SOBECO established?
SOBECO was established in November 2011.
What is SOBECO's objective?
SOBECO's objective is to reduce alcohol-related car accidents and enhance the safety of alcohol consumption by developing a drug that rapidly mitigates the effects of alcohol.
What is the current status of SOBECO?
SOBECO is currently inactive, with its status changed in December 2016.
What is SOBECO's current funding stage?
SOBECO is in the Pre-Funding stage.
In which country is SOBECO headquartered?
SOBECO is headquartered in Israel, specifically in Tel Aviv-Yafo.

Team · 1

Founder · Founder
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals

Highlights

Verified

Tags

pharmaceuticals
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

Identifiers & details

Founded2011-1
Employees (exact)6
Status reasonNon Active, Dec 2016